| Market Cap | 145.56M | P/E | - | EPS this Y | 33.30% | Ern Qtrly Grth | - |
| Income | -16.55M | Forward P/E | -39.91 | EPS next Y | 66.70% | 50D Avg Chg | -24.00% |
| Sales | 44.31M | PEG | -0.59 | EPS past 5Y | - | 200D Avg Chg | -8.00% |
| Dividend | N/A | Price/Book | 6.38 | EPS next 5Y | 25.00% | 52W High Chg | -47.00% |
| Recommedations | 2.50 | Quick Ratio | 0.73 | Shares Outstanding | 182.28M | 52W Low Chg | 45.00% |
| Insider Own | 1.99% | ROA | -11.44% | Shares Float | 85.11M | Beta | 0.44 |
| Inst Own | 69.19% | ROE | -54.22% | Shares Shorted/Prior | 1.80M/2.29M | Price | 0.80 |
| Gross Margin | 61.49% | Profit Margin | -37.36% | Avg. Volume | 881,590 | Target Price | 1.38 |
| Oper. Margin | -34.76% | Earnings Date | May 11 | Volume | 7,393,697 | Change | -20.19% |
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.
| Roth Capital | Buy | Sep 22, 21 |
| Aegis Capital | Buy | Aug 19, 21 |
| Aegis Capital | Buy | Feb 11, 21 |
| Aegis Capital | Buy | Aug 14, 20 |
| Canaccord Genuity | Buy | Jul 28, 20 |
| Aegis Capital | Buy | May 14, 20 |
| Jefferies | Hold | Nov 23, 16 |
| Rodman & Renshaw | Buy | Mar 16, 16 |
| Jefferies | Hold | May 20, 15 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Marrone Pamela G | Director Director | Jul 06 | Option | 0.80 | 20,000 | 16,000 | 2,199,134 | 07/07/22 |
| Marrone Pamela G | Director Director | Jun 09 | Sell | 1.1771 | 20,492 | 24,121 | 2,179,134 | 06/13/22 |
| Marrone Pamela G | Director Director | May 24 | Sell | 1.148 | 21,009 | 24,118 | 2,199,626 | 05/25/22 |
| Marrone Pamela G | Director Director | Mar 24 | Option | 0.8 | 20,000 | 16,000 | 2,243,363 | 03/28/22 |
| Marrone Pamela G | Director Director | Mar 24 | Sell | 1.11 | 22,728 | 25,228 | 2,220,635 | 03/28/22 |